Loading organizations...
Loading organizations...
Engineered cell therapy technologies for targeted cancer treatments.
Link Cell Therapies has raised $60.0M across 1 funding round.
Link Cell Therapies has raised $60.0M in total across 1 funding round.
Link Cell Therapies has raised $60.0M in total across 1 funding round.
Link Cell Therapies's investors include Johnson & Johnson Innovation, Abraham Bassan, Sheatree Capital, Wing Venture Capital.
Link Cell Therapies has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series A in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 15, 2025 | $60.0M Series A | Johnson & Johnson Innovation | Abraham Bassan, Sheatree Capital, Wing Venture Capital |